Nautilus Biotechnolgy, Inc. (NAUT)

NASDAQ

$2.62

$+0.07

(+2.55%)

Pre-Market

Nautilus Biotechnolgy, Inc. (NAUT) Live Price Chart

Last updated: ⁦2026-10-21 08:29:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Nautilus Biotechnolgy, Inc. (NAUT) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $2.62, with a market capitalization of $334.68M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.84 to $4.31. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$334.68M
Open	$2.55
Day's High	$12.38
Day's Low	$0.62
Previous Close	$2.55
Volume	4.03K
Average Volume	4.01M
P/E Ratio	--
52-Week High	$4.31
52-Week Low	$0.84
Dividend Yield	--
Earnings Date	--

Nautilus Biotechnolgy, Inc. (NAUT) Pre-Market Stock Price

Nautilus Biotechnolgy, Inc. (NAUT) is trading at $2.62 in pre-market trading as of 2026-10-21 08:26:00, up 2.55% ($0.07) from the previous close of $2.55

Pre-market trading shows how investors are pricing NAUT before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Nautilus Biotechnolgy, Inc. (NAUT) 7-Day Stock Price Change

Over the past seven days, Nautilus Biotechnolgy, Inc. (NAUT) moved from $2.17 to $2.62, representing a gain of 20.51% ($0.45).

The stock traded between $1.86 and $2.71 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 9.90 million shares, down versus the previous seven-day period, indicating lower trading activity.

NAUT 52-Week Price Position

Position in Range: 51.1%

52W Low$0.84

52W High$4.31

NAUT is currently trading at $2.62, placing it 51.1% of the way from its 52-week low of $0.84 to its 52-week high of $4.31. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Nautilus Biotechnolgy, Inc. (NAUT)?

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.

Nautilus Biotechnolgy, Inc. Information

Industry	LABORATORY ANALYTICAL INSTRUMENTS
Employees	130
Exchange	NASDAQ
Company Website	https://www.nautilus.bio

How to Buy Nautilus Biotechnolgy, Inc. (NAUT) Stock on MEXC

Eligible investors can buy real shares of Nautilus Biotechnolgy, Inc. (NAUT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for NAUT and Place Your Order

Open the RealStocks trading page and search for NAUT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Nautilus Biotechnolgy, Inc. (NAUT) stock price today?

Nautilus Biotechnolgy, Inc. (NAUT) is currently trading at $ 2.62, up 2.55% ($0.07) from the previous close of $ 2.55. Intraday prices update in real time during regular trading hours.

2.Is NAUT stock going up or down today?

As of 2026-10-21 08:26:00, NAUT is trading at $ 2.62, up 2.55% ($0.07) from its previous close of $ 2.55. The stock has traded between $ 0.62 and $ 12.38 during today’s regular session. Past price movements do not guarantee future results.

3.What is NAUT pre-market price?

As of 2026-10-21 08:26:00, NAUT is trading at $ 2.62 in pre-market trading, up 2.55% ($0.07) from the previous close of $ 2.55. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is NAUT after-hours price?

As of 2026-10-21 08:26:00, NAUT is trading at $ 2.55 in after-hours trading, up 0.04% ($0.00) from the regular-session close of $ 2.55. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is NAUT stock trading now?

NAUT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does NAUT sit relative to its 52-week high and low?

Over the past 52 weeks, NAUT has traded between a low of $ 0.84 and a high of $ 4.31. At $ 2.62, the stock is positioned 51.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Nautilus Biotechnolgy, Inc. in?

Nautilus Biotechnolgy, Inc. (NAUT) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Nautilus Biotechnolgy, Inc.'s market capitalization and where is it listed?

Nautilus Biotechnolgy, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 334.68M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is NAUT valued in terms of P/E ratio and EPS?

NAUT trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.44. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Nautilus Biotechnolgy, Inc. pay a dividend?

Nautilus Biotechnolgy, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.